The Omicron variant of COVID-19 is raging around the world. How does it differ from the original virus and the Delta strain? Will Omicron mark the last big wave of the virus? And how do the three different kinds of vaccines work relative to the way the human body develops immunity on its own?

Ray Blanco is the science advisor to Consilience. He shares his investment research in Technology Profits Confidential and Ray Blanco’s Catalyst Trader, where he breaks down the science behind potential investments in technology and biotechnology companies.

Ray covers a wide range of tech and biotech sectors, including semiconductors, software, cloud computing, cancer therapies and anti-aging science.

On this episode of The Wiggin Sessions, Ray joins me to share his experience of quarantine in the Philippines and explain how the Omicron variant of COVID-19 differs from previous strains. 

Ray describes the differences among mRNA, adenovirus and traditional vaccines as well as the risks associated with each, exploring how the administration’s narrative around COVID has changed and why the CDC and FDA can’t admit they were wrong about the pandemic.

Listen in for insight on the benefits of the emerging Novavax vaccine and find out why Ray is bullish on investing in biotech companies right now.

Key Takeaways  

Ray’s experience of COVID and quarantine in the Philippines

What happens when the COVID virus mutates into a new strain and how the Omicron variant differs from previous iterations

The Chinese paper around the potential mouse origin of Omicron

What happens from a scientific perspective when we contract Omicron and develop a memory of the virus in our immune system

The differences among mRNA vaccines, adenovirus vaccines and traditional vaccines

The risks associated with mRNA and adenovirus vaccines and why it’s not unreasonable to be concerned about their long-term effects

The purpose of getting a booster when our antibody counts drop

How the administration’s narrative re: COVID-19 has changed (and why it’s impossible for agencies like the CDC and FDA to admit they were wrong)

Ray’s insight on the benefits of the Novavax COVID vaccine

Why Ray is bullish on investing in biotech companies right now

Connect with Ray Blanco 

Technology Profits Confidential

Ray Blanco’s Catalyst Trader

Connect with Addison Wiggin

Consilience Financial

Be sure to follow The Wiggin Sessions on your socials. You can find me on—

Facebook @thewigginsessions

Instagram @thewigginsessions

Twitter @WigginSessions

Resources 

5-Minute Forecast

‘Evidence for a Mouse Origin of the SARS-CoV-2 Omicron Variant’ in the Journal of Genetics and Genomics

Novavax Coronavirus Vaccine

JP Morgan 2022 Health Care Conference 

Sangamo Therapeutics 

Editas Medicine

CRISPR Therapeutics